NCT01448031View on ClinicalTrials.gov

A Healthy Female and Male Volunteers Aspirin Study

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Healthy
Interventions
DRUG

Capsule ASA 81mg/esomeprazole 20mg

Multiple doses administered on Day 1 to 5

DRUG

Acetylsalicylzuur Apotex Cardio

Multiple doses administered on Day 1 to 5

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY